Excellagen – New Treatment for Diabetic Foot Ulcers | Diabetes and Foot Care | Debridement

Excellagen is a new, highly-refined bovine Type I collagen–based topical gel designed to support favorable wound care management. Excellagen's unique high molecular weight sterile, collagen formulation is topically applied through easy to control, pre-filled, single-use syringes. It is recommended that Excellagen be applied during debridement in the presence of blood cells and platelets, which are involved with the release of endogenous growth factors.¹

Excellagen is indicated for the management of wounds including partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/ undermined wounds, surgical wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, and skin tears) and draining wounds. Excellagen is contraindicated for individuals with a known sensitivity to products of bovine origin.

Excellagen is for use by healthcare professionals in the United States. All information, including the prescribing information for Excellagen, follows laws, regulatory requirements, and medical practices for the United States only and may not be appropriate for use outside of the United States. Detailed information about Excellagen can be found in the Package Insert and the Directions for Use.

¹Fufa D, Shealy B, Jacobson M, Kevy S, Murray MM. Activation of platelet-rich plasma using soluble type I collagen. J Oral Maxillofac Surg. 2008 Apr;66(4):684-90.